Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapy.
Daniel J CanterStephen FreedlandSaradha RajamaniMaria LatsisMargaret VarianoShams HalatJonathan D TwardTodd CohenSteven StoneThorsten SchlommJay BishoffStephen BardotPublished in: Prostate cancer and prostatic diseases (2019)
Both CCP and CCR scores provided independent prognostic information for predicting progression to metastatic disease after both surgery and radiation. These results further demonstrate their potential use as a risk stratification tool in patients with newly-diagnosed prostate cancer.
Keyphrases
- cell cycle
- newly diagnosed
- prostate cancer
- cell proliferation
- ultrasound guided
- squamous cell carcinoma
- radical prostatectomy
- small cell lung cancer
- coronary artery bypass
- dendritic cells
- radiation therapy
- healthcare
- radiation induced
- risk assessment
- climate change
- bone marrow
- mesenchymal stem cells
- cell therapy
- atrial fibrillation
- replacement therapy